World Health Organization. Ageing and health. World Health Organization. 2022. https://libguides.liberty.edu/ama/whoreports. Accessed 30 June 2024.
Health AIo, Welfare. Older Australians. 2023. https://www.aihw.gov.au/reports/older-people/older-australians. Accessed 30 June 2024.
Caplan Z. US older population grew from 2010 to 2020 at fastest rate since 1880 to 1890. United States Census Bureau. 2023. 2020 Census: 1 in 6 People in the United States Were 65 and Over. Accessed 30 June 2024.
World Health Organization. Life expectancy and healthy life expectancy. World Health Organization. 2020. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/life-expectancy-at-birth-(years). Accessed 30 June 2024.
Malani P, Kullgren J, Solway E, et al. National poll on healthy aging: older adults’ preparedness to age in place. April 2022. https://doi.org/10.7302/4278.
US. Dept of Health and Human Services. 2023 profile of older Americans. The Administration for Community Living; 2024. https://acl.gov/sites/default/files/Profile%20of%20OA/ACL_ProfileOlderAmericans2023_508.pdf. Accessed 30 June 2024.
Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314(17):1818–31. https://doi.org/10.1001/jama.2015.13766.
Article CAS PubMed PubMed Central Google Scholar
Innes GK, Ogden CL, Crentsil V, Concato J, Fakhouri TH. Prescription medication use among older adults in the US. JAMA Intern Med. Published online July 1, 2024. https://doi.org/10.1001/jamainternmed.2024.2781.
Sirois C, Domingues NS, Laroche ML, et al. Polypharmacy definitions for multimorbid older adults need stronger foundations to guide research, clinical practice and public health. Pharmacy (Basel). 2019. https://doi.org/10.3390/pharmacy7030126.
Article PubMed PubMed Central Google Scholar
Gebreyohannes EA, Gebresillassie BM, Mulugeta F, Dessu E, Abebe TB. Treatment burden and health-related quality of life of patients with multimorbidity: a cross-sectional study. Qual Life Res. 2023;32(11):3269–77. https://doi.org/10.1007/s11136-023-03473-3.
Article PubMed PubMed Central Google Scholar
Van Wilder L, Devleesschauwer B, Clays E, Pype P, Vandepitte S, De Smedt D. Polypharmacy and health-related quality of life/psychological distress among patients with chronic disease. Prev Chronic Dis. 2022;19:E50. https://doi.org/10.5888/pcd19.220062.
Article PubMed PubMed Central Google Scholar
Yue Z, Xue X, Qian J. The association between polypharmacy and health-related quality of life among older adults with prostate cancer. J Geriatr Oncol. 2024;15(5): 101772. https://doi.org/10.1016/j.jgo.2024.101772.
Article CAS PubMed Google Scholar
Shalihin SE, Fauzi A, Zulkifli NA, Aziz AA. Anti-diabetic medication burden amongst older persons with diabetes and associated quality of life. Med J Malays. 2020;75(5):525–30.
Al-Mansouri A, Hamad AI, Al-Ali FS, et al. Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease. Saudi Pharm J. 2023;31(5):678–86. https://doi.org/10.1016/j.jsps.2023.03.008.
Article PubMed PubMed Central Google Scholar
Hughes CM, Cooper JA, Ryan C. Going beyond the numbers—a call to redefine polypharmacy. Br J Clin Pharmacol. 2014;77(6):915–6. https://doi.org/10.1111/bcp.12284.
Article PubMed PubMed Central Google Scholar
Vyas A, Kang F, Barbour M. Association between polypharmacy and health-related quality of life among US adults with cardiometabolic risk factors. Qual Life Res. 2020;29(4):977–86. https://doi.org/10.1007/s11136-019-02377-5.
Babcock ZR, Kogut SJ, Vyas A. Association between polypharmacy and health-related quality of life among cancer survivors in the United States. J Cancer Surviv. 2020;14(1):89–99. https://doi.org/10.1007/s11764-019-00837-y.
Aljeaidi MS, Haaksma ML, Tan ECK. Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study. Qual Life Res. 2022;31(9):2663–71. https://doi.org/10.1007/s11136-022-03136-9.
Article PubMed PubMed Central Google Scholar
McNeil JJ, Woods RL, Nelson MR, et al. Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study. J Gerontol A Biol Sci Med Sci. 2017;72(11):1586–93. https://doi.org/10.1093/gerona/glw342.
Article PubMed PubMed Central Google Scholar
ASPREE Investigator Group. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemp Clinl Trials. 2013;36(2):555–64. https://doi.org/10.1016/j.cct.2013.09.014.
Ernst ME, Broder JC, Wolfe R, et al. Health characteristics and aspirin use in participants at the baseline of the ASPirin in Reducing Events in the Elderly-eXTension (ASPREE-XT) observational study. Contemp Clin Trials. 2023;130: 107231. https://doi.org/10.1016/j.cct.2023.107231.
Article PubMed PubMed Central Google Scholar
McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379(16):1499–508. https://doi.org/10.1056/nejmoa1800722.
Article CAS PubMed PubMed Central Google Scholar
McNeil JJ, Wolfe R, Woods RL, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379(16):1509–18. https://doi.org/10.1056/nejmoa1805819.
Article CAS PubMed PubMed Central Google Scholar
McNeil JJ, Nelson MR, Woods RL, et al. Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med. 2018;379(16):1519–28. https://doi.org/10.1056/nejmoa1803955.
Article CAS PubMed PubMed Central Google Scholar
Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33. https://doi.org/10.1097/00005650-199603000-00003.
Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 Physical and Mental Health Summary Score. 2nd ed. Boston: The Health Institute, New England Medical Center; 1995.
Irwin M, Artin KH, Oxman MN. Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med. 1999;159(15):1701–4. https://doi.org/10.1001/archinte.159.15.1701.
Article CAS PubMed Google Scholar
Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84. https://doi.org/10.1016/S07493797(18)30622-6.
Article CAS PubMed Google Scholar
Wang L, Palmer AJ, Cocker F, Sanderson K. Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL. Health Qual Life Outcomes. 2017;15(1):7. https://doi.org/10.1186/s12955-016-0580-x.
Article PubMed PubMed Central Google Scholar
Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, De Vries GJ, Epperson CN, Govindan R, Klein SL, Lonardo A, Maki PM, McCullough LD, Regitz-Zagrosek V, Regensteiner JG, Rubin JB, Sandberg K, Suzuki A. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–82. https://doi.org/10.1016/S0140-6736(20)31561-0.
Article PubMed PubMed Central Google Scholar
Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-Analysis. JAMA Netw Open. 2023;6(8): e2326910. https://doi.org/10.1007/s11096-024-01769-z.
Article PubMed PubMed Central Google Scholar
Hughes JE, Bennett KE, Cahir C. Drug–drug interactions and their association with adverse health outcomes in the older community-dwelling population: a prospective cohort study. Clin Drug Investig. 2024;44(6):439–53. https://doi.org/10.1007/s40261-024-01369-9.
Article CAS PubMed PubMed Central Google Scholar
Gebreyohannes EA, Shibe BS, Taye WA, Lee K, Abdela OA, Ayele EM, Belachew EA, Mengistu SB, Myint PK, Soiza RL. Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study. Int J Clin Pharm. 2024;46(6):1352–61. https://doi.org/10.1007/s11096-024-01769-z. (Epub 2024 Jul 15).
Article PubMed PubMed Central Google Scholar
Irons
Comments (0)